2021 Alzheimer Update
We are thrilled to invite you to our 2021 Update on Alzheimer’s Disease. The annual forum is an opportunity for us to share the latest developments towards effective treatments for Alzheimer’s and other dementias, as well as our ongoing work at UBC to combat dementia.
COVID-19 continues to dominate the headlines, and the continuing pandemic has been extraordinarily challenging to many patients and families living with dementia. On the positive side, those living in care homes as well as their loved ones were vaccinated on a priority basis, allowing for at least limited, yet critical, visitations from family.
Last year marked the first time we organized the annual public forum by video teleconference. This was well received by those who attended, and while we did not have a choice but to continue this for 2021, the increased reach and convenience of this format may render it the preferred platform for future meetings.
Since the end of 2020 there have been some noteworthy developments in the Alzheimer’s field. Several more clinical trials have been published, especially related to amyloid therapy, and there is a continued progress in our ability to diagnose Alzheimer’s disease, even at a stage prior to experiencing any symptoms such as memory impairments. In addition, treatments for other forms of dementia, such as frontotemporal dementia, is gradually moving towards increased clinical testing.
We are excited to share these developments and many other topics at the meeting this year, through a series of short talks by experts in the field.
We look forward to seeing you May 29!
Haakon B. Nygaard, MD, PhD
Director, UBC Hospital for Alzheimer Disease and Related Disorders